In the Key Players in Genetic Testing report, Insider Intelligence gives an overview of the four genetic testing companies — 23andMe, Ancestry, Color, and Invitae — that are racing to the forefront of healthcare.
The human genome was sequenced — or read in its entirety — for the first time in 2003, after more than 20 years of work.
In the ensuing decades, genetic information catapulted into mainstream healthcare driven largely by the rapid decline in cost for DNA sequencing technology.
Today, there is a massive opportunity for genetic testing firms to help healthcare organizations use DNA to steer more personalized treatments.
In the Key Players in Genetic Testing report, Insider Intelligence gives an overview of the four genetic testing companies — 23andMe, Ancestry, Color, and Invitae — that are racing to the forefront of healthcare.
You can access the full report by clicking below and filling out the form with a valid business email address. |
|
|
| |
| |
